Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Marginal Zone Lymphoma
.
Show all posts
Showing posts with label
Marginal Zone Lymphoma
.
Show all posts
Saturday, March 6, 2021
FDA Approves Ukoniq (umbralisib) for Marginal Zone Lymphoma and Follicular Lymphoma
›
TG Therapeutics, Inc, announced the U.S. Food and Drug Administration (FDA) approval of Ukoniq (umbralisib), for the treatment of adult p...
Saturday, October 5, 2019
FDA Approves Revlimid (lenalidomide) In Combination with Rituximab for the Treatment of Adult Patients with Previously Treated Follicular Lymphoma or Marginal Zone Lymphoma
›
In continuation of my update on lenalidomide Celgene Corporation, announced the U.S. Food and Drug Administration (FDA) approve...
›
Home
View web version
